Lowering the burden of Ebola
In response to the Ebola epidemic in West Africa, a Horizon 2020 EU research initiative ‘EVIDENT’ was launched in November 2014. Equipped with a budget of € 1.7 million, the two-year EVIDENT project provides a research platform which builds upon the success of the European Mobile Laboratory consortium (EMLab) that is performing Ebola Virus Disease (EVD) diagnostics in affected West African countries since March 2014. EVIDENT’s mandate is to scientifically exploit specimens from EVD patients collected as part of the outbreak response in Guinea, Sierra Leone and Nigeria and to gather critical knowledge on B and T cell immunology, biomarkers, virus evolution, virulence determinants, and transmission of Ebola Virus.
News & Events
This year, the "Society Needs Science" Award of the Stifterverband (Donors' Association...
The Final Meeting of the EVIDENT consortium took place at the Institute of Molecular Biology and...
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March
Journal of Infectious Diseases (2016), 10.1093/infdis/jiw269
Medical Microbiology and Immunology (2016), doi: 10.1007/s00430-015-0438-6
EVIDENT Fact Sheet
The most important project facts at a glance.Download